StockpollyBeta
Get App
Popularity #5,125
PLUR · NASDAQ · Biotechnology

Pluri (PLUR)

Expands cells for therapies, manufacturing and cultivated-food ventures.

$1.13
After hours+0.02 (+1.80%)
At close$1.11(+3.74%)

In millions of USD, except per-share figures

In millionsQ1 FY24Sep 2023Q2 FY24Dec 2023Q3 FY24Mar 2024Q4 FY24Jun 2024Q1 FY25Sep 2024Q2 FY25Dec 2024Q3 FY25Mar 2025Q4 FY25Jun 2025Q1 FY26Sep 2025Q2 FY26Dec 2025Q3 FY26Mar 2026Q4 FY26Jun 2026
Revenue000000000000
Cost of revenue000000000000
Gross profit000000000000
556655676676
Research & development333333344443
223332232332
General & administrative223332232333
Other expenses000000000000
Operating income−5−5−6−6−5−5−5−7−6−7−7−6
0000−12−1−1000−1
Interest income000100000000
Interest expense000000000000
Other non-operating income00001−2110000
Income before tax−5−5−5−6−6−3−6−8−6−7−6−6
Income tax expense000000000000
Net income from continuing operations−5−5−5−6−6−3−6−8−6−7−6−6
Net income−5−5−5−6−6−3−6−8−6−7−6−6
EPS, basic−$0.96−$0.94−$1.01−$1.06−$1.12−$0.53−$1.14−$0.96−$0.65−$0.71−$0.55−$0.54
EPS, diluted−$0.96−$0.94−$1.01−$1.06−$1.12−$0.53−$1.14−$0.96−$0.65−$0.71−$0.55−$0.54
Weighted average shares, basic55555668991011
Weighted average shares, diluted55555668991011
EBITDA−5−5−5−6−6−3−6−7−6−7−6−5
Depreciation & amortization000000000000
EBIT−5−5−5−6−6−3−6−8−6−7−6−6